Protein
Description 806 amino acids; 115 kDa; tyrosine kinase receptor; contains three major domains: an extracellular domain with 3 Ig-like loops, a highly hydrophobic transmembrane domain (22 amino acids) and an intracellular domain with tyrosine kinase activity.
Expression
Mostly in brain, cartilage, liver, inner ear, kidney.
Localisation
Plasma membrane.
Function
FGF receptor with tyrosine kinase activity; binding of ligand (FGF) induces receptor dimerization, autophosphorylation and signal transduction.
Homology
With other FGFR (1, 2 and 4); Cek 2 in chicken. 
Prognosis
Unknown: found in 11 cases, but with no data on clinics.
Abnormal Protein
No fusion protein, but promoter exchange between both partner genes.
Oncogenesis
Overexpression and activation of FGFR 3 provides an oncogenic signal.
Squeletal dysplasia (inborn diseases)
Disease Hypochondroplasia, achondroplasia, thanatophoric dwarfism (TD I and II), Crouzon syndrome with acanthosis nigricans and coronal craniosynostosis; endochondral and membranous ossification defects are caused by recurrent missense mutations.
